Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04000087 · ClinicalTrials.gov registry record · NA
ECG AI-Guided Screening for Low Ejection Fraction
A NA study of Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction (Disorder), sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 358
- Enrollment target
- 1
- Study location
NCT04000087 is a NA study of Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction (Disorder) that has completed, run by Mayo Clinic. The registered enrollment target is 358 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04000087, a NA study of Heart Failure and Asymptomatic Left Ventricular Systolic Dysfunction (Disorder), has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 358 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.
Conditions Studied
Interventions
- OTHER AI-enabled ECG-based Screening Tool
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 358 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2020-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04000087
The ClinicalTrials.gov registry entry for NCT04000087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 358 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (83% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which AI-enabled ECG-based Screening Tool is the first listed.
NCT04000087 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04000087 about?
NCT04000087 is a clinical study titled "ECG AI-Guided Screening for Low Ejection Fraction". This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of left ventricular systolic dysfunction.
What is the current status of trial NCT04000087?
This trial is currently completed. It is a NA study. The enrollment target is 358 participants. The study started on 2019-06-26. Estimated completion is 2020-11-01.
What conditions does trial NCT04000087 study?
This clinical trial studies the following conditions: Heart Failure, Asymptomatic Left Ventricular Systolic Dysfunction (Disorder).
What interventions are being tested in trial NCT04000087?
The interventions under investigation include: AI-enabled ECG-based Screening Tool (OTHER).
Who is sponsoring clinical trial NCT04000087?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04000087 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Heart Failure
All registered trials for this condition
Asymptomatic Left Ventricular Systolic Dysfunction (Disorder)
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.